GI
CORT icon

GAMMA Investing’s Corcept Therapeutics CORT Stock Holding History

GAMMA Investing’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Buy
4,640
+1,627
+54% +$98.2K 0.02% 772
2026
Q1 		$121K Sell
3,013
-1,863
-38% -$69.7K 0.01% 1523
2025
Q4 		$170K Buy
4,876
+239
+5% +$18.8K 0.01% 1158
2025
Q3 		$385K Buy
4,637
+857
+23% +$62K 0.02% 600
2025
Q2 		$277K Buy
3,780
+373
+11% +$27K 0.02% 711
2025
Q1 		$389K Buy
3,407
+411
+14% +$25K 0.03% 505
2024
Q4 		$151K Buy
2,996
+506
+20% +$26.5K 0.01% 848
2024
Q3 		$115K Buy
2,490
+1,147
+85% +$40.8K 0.01% 906
2024
Q2 		$43.6K Buy
1,343
+125
+10% +$3.42K 0.01% 1299
2024
Q1 		$30.7K Buy
1,218
+579
+91% +$13.7K 0.01% 1354
2023
Q4 		$13.5K Buy
+639
New +$17.5K ﹤0.01% 1739

Other funds holding CORT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

GAMMA Investing's CORT Position: Q2 2026 in Review

GAMMA Investing increased its Corcept Therapeutics (CORT) stake by 54% in Q2 2026, buying an estimated $98.2K and bringing the position to 4,640 shares worth $403K. The position accounts for 0.02% of the portfolio, ranked #772.

GAMMA Investing first reported a position in CORT in Q4 2023 and has held it in 11 quarters since. 62 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • GAMMA Investing held 4,640 shares of Corcept Therapeutics worth $403K as of Q2 2026.
  • GAMMA Investing bought 1,627 Corcept Therapeutics shares in Q2 2026, an estimated $98.2K.
  • Corcept Therapeutics made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #772 holding.
  • GAMMA Investing first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 62 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.